Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 26:10:499.
doi: 10.3389/fphys.2019.00499. eCollection 2019.

Crohn's Disease in Clinical Remission Is Marked by Systemic Oxidative Stress

Arno R Bourgonje  1 , Julius Z H von Martels  1 , Marian L C Bulthuis  2 , Marco van Londen  3 , Klaas Nico Faber  1 , Gerard Dijkstra  1 , Harry van Goor  2
Affiliations

Crohn's Disease in Clinical Remission Is Marked by Systemic Oxidative Stress

Arno R Bourgonje et al. Front Physiol. .

Abstract

Introduction: Crohn's disease (CD) is characterized by chronic and relapsing inflammation of the gastro-intestinal tract. It is assumed that oxidative stress contributes to CD pathogenesis, but systemic biomarkers for oxidative stress in CD are not yet identified. A reduction in free thiol groups in plasma proteins ("plasma free thiols") reflects systemic oxidative stress since they are prime substrates for reactive oxygen species. Here, we determined the concentrations of plasma free thiols in CD patients and healthy controls and studied the putative correlation with disease parameters. Methods: Free thiols were quantified in plasma of patients with CD in clinical remission [according to the Harvey Bradshaw Index (HBI)] and healthy controls and adjusted for plasma albumin. Albumin-adjusted free thiol concentrations were analyzed for associations with clinical and biochemical disease markers. Results: Mean plasma free thiol concentrations were significantly lower in patients with CD (n = 51) compared to healthy controls (n = 27) (14.7 ± 2.4 vs. 17.9 ± 1.8 μmol/g albumin; P < 0.001). Patients with CD with above-average free thiols had significantly lower CRP levels (median 1.4 [interquartile range] [0.4; 2.6] vs. 3.6 [0.6; 7.0] mg/L; P < 0.05) and BMI (23.6 ± 4.8 vs. 27.1 ± 5.2 kg/m2; P < 0.05). Patients with CD having solely colonic disease demonstrated markedly reduced plasma free thiol concentrations compared to patients with ileocolonic involvement (13.2 ± 1.8 vs. 15.2 ± 2.2 μmol/g; P < 0.05). Finally, plasma free thiol concentrations negatively correlated with biomarkers of inflammation, including hsCRP, SAA, IL-17A (all P < 0.05), and VEGF. Conclusion: Plasma free thiols are reduced in patients with CD in clinical remission compared to healthy controls. Thus, subclinical CD disease activity is reflected by systemic oxidative stress and plasma free thiols may be a relevant therapeutic target and biomarker to monitor disease activity in CD.

Keywords: Crohn’s disease; biomarker; disease activity; free thiols; oxidative stress; redox status.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Albumin-adjusted plasma free thiols (μmol/g) are highly significantly reduced in Crohn’s disease (CD) patients compared to healthy controls (HC) (∗P < 0.001).
FIGURE 2
FIGURE 2
Albumin-adjusted plasma free thiols (μmol/g) are most prominently reduced in CD patients having solely colonic disease (colonic vs. ileocolonic CD, ∗P < 0.05), according to the Montreal classification of disease localization.
FIGURE 3
FIGURE 3
Serum levels of (A) high-sensitive CRP (hsCRP), (B) serum amyloid A (SAA), (C) interleukin-17A (IL-17A), and (D) vascular endothelial growth factor (VEGF) correlate with albumin-adjusted plasma free thiols (μmol/g).
See this image and copyright information in PMC

References

    1. Abraham C., Cho J. H. (2009). Inflammatory bowel disease. N. Engl. J. Med. 361 2066–2078. - PMC - PubMed
    1. Alzoghaibi M. A. (2013). Concepts of oxidative stress and antioxidant defense in Crohn’s disease. World J. Gastroenterol. 19 6540–6547. 10.3748/wjg.v19.i39.6540 - DOI - PMC - PubMed
    1. Anraku M., Chuang V. T., Maruyama T., Otagiri M. (2013). Redox properties of serum albumin. Biochim. Biophys. Acta 1830 5465–5472. 10.1016/j.bbagen.2013.04.036 - DOI - PubMed
    1. Ates I., Kaplan M., Yuksel M., Mese D., Alisik M., Erel Öet al. (2016). Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine 51 47–51. 10.1007/s12020-015-0784-6 - DOI - PubMed
    1. Atkuri K. R., Mantovani J. J., Herzenberg L. A., Herzenberg L. A. (2007). N-Acetylcysteine—a safe antidote for cysteine-glutathione deficiency. Curr. Opin. Pharmacol. 7 355–359. 10.1016/j.coph.2007.04.005 - DOI - PMC - PubMed